5,695
Views
20
CrossRef citations to date
0
Altmetric
Coronavirus – Research Paper

Socio-demographic, psychological, and experiential predictors of COVID-19 vaccine hesitancy in South Korea, October-December 2020

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1-8 | Received 15 Jun 2021, Accepted 15 Sep 2021, Published online: 06 Oct 2021
 

ABSTRACT

Vaccine hesitancy is the primary barrier to controlling the COVID-19 pandemic in South Korea. We used logistic multivariate regression modeling to investigate (1) the prevalence and reasons for COVID-19 vaccine hesitancy, (2) sub-groups that had higher rates of vaccine hesitancy, and (3) vaccine hesitancy predictors. We used a national survey of representatively sampled households (n = 13,021 adults) from October to December 2020. A self-report questionnaire asked about vaccination intention and reasons for hesitancy and gathered data on socio-demographic, demographic, psychological, and experiential factors. Our study indicated that 39.8% of the participants answered that they hesitated or refused to be vaccinated. The most common reason for vaccine hesitancy was a lack of confidence in the COVID-19 vaccine (77.9%). Less or no fear of COVID-19 (OR = 2.08, 95% CI = 1.92–2.26; OR = 1.79, 95% CI = 1.54–2.08), unstable job status (OR = 1.42, 95% CI = 1.18–1.70), decreased family income (OR = 1.40, 95% CI = 1.21–1.61), and worsening health status (OR = 1.38, 95% CI = 1.13–1.68) were predictors of vaccine hesitancy. Younger age, no religious affiliation, political conservatism, and lower family income were also significantly associated with vaccine hesitancy. Effective health communication and policies need to consider the target subgroup population and predictors of vaccine hesitancy to attain herd immunity at an early stage.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Ethics approval and consent to participate

The Institutional Review Board of the Seoul Metropolitan Government-Seoul National University Boramae Medical Center (IRB number: 07-2021-12) approved this study.

Additional information

Funding

This study was funded by the JW LEE Center for Global Medicine of Seoul National University College of Medicine and the National Assembly Futures Institute, Seoul, the Republic of Korea.